Compounds > ncq 298
Page last updated: 2024-08-25

ncq 298 and 5-bromo-2,3-dimethoxy-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide

ncq 298 has been researched along with 5-bromo-2,3-dimethoxy-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farde, L; Hall, H; Halldin, C; Högberg, T; Larsson, S; Sedvall, G1

Reviews

1 review(s) available for ncq 298 and 5-bromo-2,3-dimethoxy-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide

ArticleYear
Imaging of dopamine receptors using PET and SPECT.
    Neurochemistry international, 1992, Volume: 20 Suppl

    Topics: Animals; Benzamides; Brain; Dopamine Agonists; Dopamine Antagonists; Humans; Macaca fascicularis; Pyrrolidines; Raclopride; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1992